OP
Oric Pharmaceuticals Inc
🇩🇪XFRA.4TZGermanyHealthcare
€10.80EURup +0.28 (+2.66%)ClosedEnd of day3:09 AM
Price€10.80+0.28 (+2.66%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US68622P1093
- CUSIP
- Not reported
Company
- Employees
- 111
- Headquarters
- South San Francisco, United States
- Website
- https://www.oricpharma.com
- CEO
- Dr. Jacob M. Chacko M.B.A., M.D.
Market
- Shares outstanding
- 103.7M
- Market cap
- €1.12B
Key dates
- Next earnings
- Nov 12, 2026
Highlights
- Market cap
- €1.09B
- EPS LTM
- -$1.30
- P/E LTM
- -8.33
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$140.35M-2.26%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$112.42M+7.52%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.